Jalid Sehouli - Gynecology

Author Information

Jalid Sehouli is affiliated with the Department of Gynecology with Center for Oncological Surgery at Charité Universitätsmedizin, located at Charité Platz 1, 10117, Berlin, Germany. His extensive research primarily focuses on gynecological oncology, particularly in ovarian cancer and related areas.

Research Contributions

Jalid Sehouli has made significant contributions to the field of gynecological oncology through his research on various aspects of ovarian cancer. His recent work includes studies on pre-operative scoring systems to predict leiomyosarcoma, genomic instability in ovarian cancer, potential therapeutic targets in mucinous ovarian cancer, and biomarkers for chemotherapy-induced polyneuropathy. His research has also explored innovative approaches in reconstructive surgery following vulvar cancer excision and the management of malignant dysgerminoma of the ovary.

Aliases

Jalid Sehouli is also known by the following aliases: J Sehouli, J. Sehouli.

Publication and Citation Metrics

Metric	Value
Total Publications	1068
Total Citation Count	25382
h-index	74

Publications:

Clinical value of pre-operative scoring systems to predict leiomyosarcoma: results of a validation study in 177 patients from the NOGGO-REGSA Registry

DOI: 10.1136/ijgc-2021-003334

Year: 2022

Genomic Instability Is Defined by Specific Tumor Microenvironment in Ovarian Cancer: A Subgroup Analysis of AGO OVAR 12 Trial

DOI: 10.3390/cancers14051189

Year: 2022

Polycomb Protein BMI-1 as a Potential Therapeutic Target in Mucinous Ovarian Cancer

DOI: 10.21873/anticanres.15650

Year: 2022

In Situ N-Glycosylation Signatures of Epithelial Ovarian Cancer Tissue as Defined by MALDI Mass Spectrometry Imaging

DOI: 10.3390/cancers14041021

Year: 2022

Neurofilament proteins as a potential biomarker in chemotherapy-induced polyneuropathy

DOI: 10.1172/jci.insight.154395

Year: 2022

Reconstructive Surgery versus Primary Closure following Vulvar Cancer Excision: A Wide Single-Center Experience

DOI: 10.3390/cancers14071695

Year: 2022

Cell-free tumor DNA, CA125 and HE4 for the objective assessment of tumor burden in patients with advanced high-grade serous ovarian cancer

DOI: 10.1371/journal.pone.0262770

Year: 2022

Management of malignant dysgerminoma of the ovary

DOI: 10.31083/j.ejgo4302041

Year: 2022

Biomarker-Based Models for Preoperative Assessment of Adnexal Mass: A Multicenter Validation Study

DOI: 10.3390/cancers14071780

Year: 2022

Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer

DOI: 10.1097/01.ogx.0000824536.49876.91

Year: 2022

Can Smoking and Alcohol Affect Menstrual Cycles?

Can Lifestyle Changes Mitigate the Risk?

What is the Emotional Toll in Gynecology?

Is CBT-I Effective?

How Can Acid Reflux Affect Pregnancy?

What is HPV?

What are the Risks of Diabetes During Menopause?

How is it Managed?

How to Prepare for MRCOG?

Is Masturbation Normal?

Partnered Content Networks

Relevant Topics